0.23
0.23 (0%)
As of Feb 14, 2025
Sunshine Biopharma, Inc [SBFMW]
Source:
Company Overview
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, includingoncology and antivirals. We have two wholly owned subsidiaries: (i) Nora Pharma Inc. (“Nora Pharma”), a Canadiancorporation, through which we currently have 70 generic prescription drugs on the market in Canada, and (ii) Sunshine BiopharmaCanada Inc. (“Sunshine Canada”), a Canadian corporation which develops and sells OTC supplements.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (332) 216-1147 |
| Industry | manufacturing |
| CEO | Dr. Steve N. Slilaty |
| Website | www.sunshinebiopharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $34.9 |
| Operating Profit | $-5.8 |
| Net Income | $-5.1 |
| Net Cash | $-5.6 |
Profit Ratios
| Gross Margin | $10.7 |
| Operating Margin | -16.7 |
| Profit as % of Revenues | -207.8% |
| Profit as % of Assets | -17.7% |
| Profit as % of Stockholder Equity | -21.9% |
Management Effectiveness
| Return on Equity | -21.9% |
| Return on Assets | -16.8% |
| Turnover Ratio | 120.5% |
| EBITA | $-5.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $30.6 |
| Total Liabilities | $7.1 |
| Operating Cash Flow | $-12.5 |
| Investing Cash Flow | $-2.3 |
| Financing Cash Flow | $9.3 |
